| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/21/2013 | CN103255043A Paraphlonia pagoda tree flower bud health-care wine and preparation method thereof |
| 08/21/2013 | CN103255031A Health care liquor |
| 08/21/2013 | CN103255021A Health preserving wine |
| 08/21/2013 | CN103254315A Recombinant TAT-MANF (trans-activator of transcription-mesencephalic astrocyte derived neurotrophic factor) fusion protein and application thereof |
| 08/21/2013 | CN103254278A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 08/21/2013 | CN103254207A Compound with antihypertensive activity and preparation method thereof |
| 08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254188A Azilsartan derivative and preparation method thereof |
| 08/21/2013 | CN103254119A Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 08/21/2013 | CN103254114A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
| 08/21/2013 | CN103251956A Matrine-montmorillonite nano composite and preparation method thereof |
| 08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 08/21/2013 | CN103251928A Anti-hypertensive agent |
| 08/21/2013 | CN103251926A Traditional Chinese medicine leech extract product and its application |
| 08/21/2013 | CN103251917A Traditional Chinese medicine suppository for treating gynecological diseases |
| 08/21/2013 | CN103251907A Compound essential oil for effectively relieving arteriosclerosis |
| 08/21/2013 | CN103251905A Chinese herbal compound composition for treating varicosity |
| 08/21/2013 | CN103251891A Chinese medicinal external-application ointment for treating qi-stagnation and blood stasis type unstable angina |
| 08/21/2013 | CN103251887A Pharmaceutical composition for treating diabetes and indications thereof |
| 08/21/2013 | CN103251885A Traditional Chinese medicine composition for treating dilated cardiomyopathy and preparation method thereof |
| 08/21/2013 | CN103251855A Traditional Chinese medicine composition for treating damp-heat-downward-flow type haemorrhoids |
| 08/21/2013 | CN103251829A Chinese herbal medicine formula ointment for treating hypertension and preparation method thereof |
| 08/21/2013 | CN103251822A Qi-tonifying and dizziness-relieving Chinese medicine preparation for treating ischemic stroke, coronary disease and angina |
| 08/21/2013 | CN103251814A Traditional Chinese medicine preparation for adjusting hypertension, hyperlipemia and hyperglycemia |
| 08/21/2013 | CN103251806A Chinese medicine gel for preventing chemotherapeutic phlebitis and preparation method of Chinese medicine gel |
| 08/21/2013 | CN103251803A Formula and process of health-assistant wine |
| 08/21/2013 | CN103251777A Application of aloe |
| 08/21/2013 | CN103251764A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 08/21/2013 | CN103251743A Formulation for enhancing immunity, improving cardiovascular function and delaying senescence |
| 08/21/2013 | CN103251735A Chinese medicine for treating paroxysmal supraventricular tachycardia |
| 08/21/2013 | CN103251717A Traditional Chinese medicine composition (toxin-expelling and skin-beautifying tablet) and preparation method thereof |
| 08/21/2013 | CN103251696A Medicament for treating apoplexia |
| 08/21/2013 | CN103251686A Composition for adjusting hyperlipemia and preparation method of composition |
| 08/21/2013 | CN103251677A Tongmai oral liquid raw material medicine extract and preparation method and application thereof |
| 08/21/2013 | CN103251675A Kudzu flavone self-microemulsifying dropping pill and preparation method thereof |
| 08/21/2013 | CN103251646A Application of rutabaga polysaccharide |
| 08/21/2013 | CN103251645A Application of Polyflavanostilbene A in preparing medicine for treating atherosclerosis |
| 08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
| 08/21/2013 | CN103251623A Application of Aspeverin in preparation of medicines for treating or preventing acute heart failure |
| 08/21/2013 | CN103251618A Application of Aspeverin in preparation of vascular dilation medicines |
| 08/21/2013 | CN103251601A Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 08/21/2013 | CN103251587A Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor |
| 08/21/2013 | CN103251585A Effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A |
| 08/21/2013 | CN103251580A Application of ampelopsin in preparation of vascular endothelial cell protection health food or drugs |
| 08/21/2013 | CN103251579A Substituted acylanilides and methods of use thereof |
| 08/21/2013 | CN103251567A Agomelatine troche and preparation method thereof |
| 08/21/2013 | CN103251557A Felodipine nano suspension and preparation method thereof |
| 08/21/2013 | CN103251554A Stable edaravone injection and preparation method thereof |
| 08/21/2013 | CN103250854A Cardiovascular disease-preventing sugar-free candy and preparation method thereof |
| 08/21/2013 | CN102813637B Kallidinogenase enteric coated tablet and preparation method thereof |
| 08/21/2013 | CN102743578B Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction |
| 08/21/2013 | CN102697766B Application of N-methyl piperonylethylamine and salts of N-methyl piperonylethylamine in preparation of drugs for preventing and/or treating encephalopathy |
| 08/21/2013 | CN102670714B Semen raphani Chinese medicine oral liquid for relieving high blood pressure and preparation method of same |
| 08/21/2013 | CN102652736B Method for preparing soybean isoflavone sustained-release microspheres |
| 08/21/2013 | CN102641420B Pharmaceutical composition for treating coronary heart disease |
| 08/21/2013 | CN102641357B Medicament for treating hypertension and preparation method thereof |
| 08/21/2013 | CN102552208B Daidzein solid dispersion micro-pill capsule and preparation method thereof |
| 08/21/2013 | CN102552156B Nimodipine freeze-dried solid lipid nanoparticle and preparation method thereof |
| 08/21/2013 | CN102526511B Chinese medicinal composition for treating hypertension |
| 08/21/2013 | CN102512520B Normal-temperature preparation method for ultrafine powder hawthorn |
| 08/21/2013 | CN102416016B Use of 1-erucic acyl-4-(3'-chloro-)benzylpiperazine in medicine preparation |
| 08/21/2013 | CN102397394B Preparation method of cephalocathartic hypertension pill |
| 08/21/2013 | CN102319307B Preparation method of Baoxin tablet |
| 08/21/2013 | CN102319212B Clevidipine butyrate structured lipid emulsion and preparation method thereof |
| 08/21/2013 | CN102302548B Preparation method for compound salvia tablets |
| 08/21/2013 | CN102210835B Traditional Chinese medicine for treating coronary disease |
| 08/21/2013 | CN102204891B Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |
| 08/21/2013 | CN102138899B Olmesartan liposome solid preparation |
| 08/21/2013 | CN102127056B Tubulin inhibitors |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/21/2013 | CN102091083B Petroleum ether extract of traditional Chinese medicine for preventing and treating glucose and lipid metabolic disturbance and preparation method thereof |
| 08/21/2013 | CN102066359B Novel heteroaryl carboxamide derivatives |
| 08/21/2013 | CN101928226B N-(2-ethoxy) feriilamidoethyl nitrate compound and preparation method thereof |
| 08/21/2013 | CN101780268B Method and reagent for diagnosing, preventing and treating insulin resistance |
| 08/21/2013 | CN101664553B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/21/2013 | CN101631785B Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 08/21/2013 | CN101607904B Propanoic acid derivatives and synthesis method and application thereof |
| 08/21/2013 | CN101544592B Process for preparation of N-arylsulfonyl-3-substituted indoles |
| 08/21/2013 | CN101478966B Compressed preparation |
| 08/21/2013 | CN101439066B Chinese medicine granular containing notoginseng extract and preparation method thereof |
| 08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513262 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513235 Homocysteine synthase inhibitor |
| 08/20/2013 | US8513230 Nuclear transport modulators and uses thereof |
| 08/20/2013 | US8513220 Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity |
| 08/20/2013 | US8513185 Inhibition of TREM receptor signaling with peptide variants |
| 08/20/2013 | US8512969 Methods for analyzing a heparin sample |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | CA2804129C Manufacturing method for dried earthworm powder |
| 08/20/2013 | CA2738214C Chewing gum containing low dose amounts of water soluble vitamins |
| 08/20/2013 | CA2723302C Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 08/20/2013 | CA2589497C Novel specific caspase-10 inhibitors |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/15/2013 | WO2013119870A1 Compositions and methods for treatment of peripheral vascular disease |
| 08/15/2013 | WO2013119331A1 Animal models of atherosclerosis |